Comparative Analysis of Cesium Chloride- and Iodixanol-Based Purification of Recombinant Adeno-Associated Viral Vectors for Preclinical Applications

Human Gene Therapy Methods

Volumn 26, Issue 4, 2015, Pages 147-157

  Strobel, Benjamin ^a   Miller, Felix D ^a   Rist, Wolfgang ^a   Lamla, Thorsten ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM CHLORIDE; DODECYL SULFATE; IODIXANOL; MACROGOL; PARVOVIRUS VECTOR; CESIUM; CHLORIDE; IODOBENZOIC ACID DERIVATIVE; MACROGOL DERIVATIVE;

ADENO ASSOCIATED VIRUS; ARTICLE; BIOLOGICAL ACTIVITY; CLINICAL PROTOCOL; COMPARATIVE STUDY; CYTOLYSIS; DENSITY GRADIENT; DENSITY GRADIENT CENTRIFUGATION; FILTRATION; GEL ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; HOLLOW FIBER; LIQUID CHROMATOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; SEROTYPE; TANDEM MASS SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAFILTRATION; VIRUS RECOMBINANT; DEPENDOPARVOVIRUS; GENE VECTOR; GENETICS; HEK293 CELL LINE; HUMAN; ISOLATION AND PURIFICATION; PROCEDURES; SIZE EXCLUSION CHROMATOGRAPHY; ULTRASTRUCTURE;

ADENO-ASSOCIATED VIRUS;

CENTRIFUGATION, DENSITY GRADIENT; CESIUM; CHLORIDES; CHROMATOGRAPHY, GEL; DEPENDOVIRUS; GENETIC VECTORS; HEK293 CELLS; HUMANS; POLYETHYLENE GLYCOLS; TRIIODOBENZOIC ACIDS;

EID: 84939789089     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2015.051     Document Type: Article

References (28)

1. Strobel B, Duechs MJ, Schmid R, et al. Modeling pulmonary disease pathways using recombinant adeno-associated virus 6.2. Am J Respir Cell Mol Biol 2015 (in press).
2. Grimm D, Pandey K, and Kay MA. Adenoassociated virus vectors for short hairpin RNA expression. Methods Enzymol 2005;392:381-405.
3. Zolotukhin S, Byrne BJ, Mason E, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999;6:973-985.
4. Klein RL, Dayton RD, Tatom JB, et al. AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol Ther 2008;16:89-96.
5. Lock M, Alvira M, Vandenberghe LH, et al. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther 2010;21:1259-1271.
6. Shevchenko A, Wilm M, Vorm O, et al. Mass spectrometric sequencing of proteins silver - stained polyacrylamide gels. Anal Chem 1996;68: 850-858.
7. Helm D, Vissers JPC, Hughes CJ, et al. Ion mobility tandemmass spectrometry enhances performance of bottom-up proteomics.Mol Cell Proteomics 2014;13: 3709-3715.
8. Biemann K. Sequencing of peptides by tandem mass spectrometry and high-energy collision - induced dissociation. Methods Enzymol 1990;193: 455-479.
9. Hermens WT, ter Brake O, Dijkhuizen PA, et al. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum Gene Ther 1999;10:1885-1891.
10. Larsen LE, Heglund IF, Fabian R, et al. Neural tolerability of iodixanol in mice and dogs after single and repeated intracisternal administration. Acta Radiol Suppl 1995;399:238-243.
11. Chadeuf G, Ciron C, Moullier P, et al. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery. Mol Ther 2005;12:744-753.
12. Tenenbaum L, Hamdane M, Pouzet M, et al. Cellular contaminants of adeno-associated virus vector stocks can enhance transduction. Gene Ther 1999;6:1045-1053.
13. Qiu J, and Brown KE. A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adenoassociated virus type 2 (AAV-2) capsid. Virology 1999;257:373-382.
14. Bevington JM, NeedhamPG, Verrill KC, et al. Adenoassociated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions. Virology 2007;357:102-113.
15. Dong B, Duan X, Chow HY, et al. Proteomics analysis of co-purifying cellular proteins associated with rAAV vectors. PLoS One 2014;9:e86453.
16. Pegoraro G,Marcello A, MyersMP, et al. Regulation of adeno-associated virus DNA replication by the cellular TAF-I/set complex. J Virol 2006;80:6855-6864.
17. Wang D, and Parrish CR. A heterogeneous nuclear ribonucleoprotein A/B-related protein binds to single-stranded DNA near the 5 end or within the genome of feline parvovirus and can modify virus replication. J Virol 1999;73:7761-7768.
18. Li X, Johansson C, Glahder J, et al. Suppression of HPV-16 late L1 5-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs. Nucleic Acids Res 2013;41:10488-10508.
19. Lévesque K, Halvorsen M, Abrahamyan L, et al. Trafficking of HIV-1 RNA is mediated by heterogeneous nuclear ribonucleoprotein A2 expression and impacts on viral assembly. Traffic 2006;7:1177-1193.
20. Shi ST, Yu G-Y, and Lai MM. Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis. J Virol 2003;77:10584-10593.
21. Katoh H, Mori Y, Kambara H, et al. Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA. J Virol 2011;85:10976-10988.
22. Maeto CA, Knott ME, Linero FN, et al. Differential effect of acute and persistent Junin virus infections on the nucleo-cytoplasmic trafficking and expression of heterogeneous nuclear ribonucleoproteins type A and B. J Gen Virol 2011;92:2181-2190.
23. Green VA, Arbuthnot P, and Weinberg MS. Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cells. Virol J 2012;9:272.
24. Miller HB, Saunders KO, Tomaras GD, et al. Tat-SF1 is not required for Tat transactivation but does regulate the relative levels of unspliced and spliced HIV-1 RNAs. PLoS One 2009;4:e5710.
25. Landi A, Vermeire J, Iannucci V, et al. Genomewide shRNA screening identifies host factors involved in early endocytic events for HIV-1-induced CD4 down-regulation. Retrovirology 2014;11:118.
26. Sikora D, Greco-Stewart VS, Miron P, et al. The hepatitis delta virus RNA genome interacts with eEF1A1, p54nrb, hnRNP-L, GAPDH and ASF/SF2. Virology 2009;390:71-78.
27. Maertens GN, Cook NJ, Wang W, et al. Structural basis for nuclear import of splicing factors by human Transportin 3. Proc Natl Acad Sci U S A 2014;111: 2728-2733.
28. Mui MZ, Kucharski M, Miron M-J, et al. Identification of the adenovirus E4orf4 protein binding site on the B55a and Cdc55 regulatory subunits of PP2A: implications for PP2A function, tumor cell killing and viral replication. PLoS Pathog 2013;9:e1003742.